Harvard Bioscience Recovers Some Ground, Agilent Spurts
Shares of Harvard Bioscience and Agilent Technologies improved 7 percent for the five-day period as the BioCommerce Week Index ended down for the fourth time in the last five weeks.
The stock of Harvard Bioscience, which reports its third-quarter financials on Friday, has lost 12 percent of its market capitalization over the last three weeks. The company recovered some ground this week after its shares neared a 52-week low last week on a downturn that started when its shares fell 45 percent following the release of the company’s Q1 results, highlighting earnings shortfalls at its Genomics Solutions unit.
Agilent, which closed at $24.33, up from $22.72 last week, was one of six BCW Index companies - Harvard Bio, BD, General Electric, Applied Biosystems, and PerkinElmer — whose shares finished up for the five-day period. Bruker closed Tuesday at $3.20, remaining unchanged for the week.
Waters, which reported earnings on Tuesday, fell 7 percent, closing at $39.19, down from last week’s $42.15, to lead stock-price losers.
The BCW index closed at $31.11, down 1 percent from last week’s $31.44. The Amex Biotech and Pharmaceutical indexes were down just under 2 percent for the five-day period, while the Dow Jones Industrials was up a fraction, and the S&P 500 and Nasdaq indexes were up a fraction under 1 percent up for the week.
Following is a list of when the BCW Index companies will report their financials for the quarter ending Sept. 30:
- Agilent Q4 2004: Nov. 11
- Becton Dickinson Q4 2004: Nov. 4
- Beckman Coulter Q3 2004: Oct. 29
- Bio-Rad Q3 2004: Nov. 4
- Bruker Q3 2004: Nov. 3
- Harvard Biosciences Q3 2004: Oct. 29
- Invitrogen Q3 2004: Oct. 28
- Molecular Devices Q3 2004: Oct. 29
- PerkinElmer Q3 2004: Oct. 29
- Stratagene Q3 2004: Nov. 8